Skip to content

Vestibular Rehabilitation and Galvanic Vestibular Stimulation in children with Spastic Cerebral Palsy

Vestibular Rehabilitation and Galvanic Vestibular Stimulation in children with Spastic Cerebral Palsy: clinical, crossover, placebo-controlled, double-blind trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-498fr3w
Enrollment
Unknown
Registered
2024-11-21
Start date
2024-08-26
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spastic cerebral palsy

Interventions

-This is a two-arm, double-blind, randomized controlled clinical study. Randomization will be carried out using a program capable of generating random numbers to distribute participants to one of the
E05.723.402

Sponsors

Irmandade da Santa Casa de Misericórdia de São Paulo
Lead Sponsor
Centro de Neuroestimulação Pediátrica
Collaborator

Eligibility

Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: Diagnosis of Spastic Cerebral Palsy; have magnetic resonance imaging demonstrating damage to the pyramidal system, without involvement of the extrapyramidal system and cerebellum; functionally classified as levels I, II or III by the Gross Motor Function Classification System (GMFCS); degree of spasticity less than three on the Modified Ashworth Scale; able to walk independently for at least 12 months, even if requiring walking aids; aged between six and twelve years; both sexes; degrees of understanding and collaboration compatible with carrying out the proposed activities; guardians agreed to their participation in the study by signing the Free and Informed Consent Form; participant acceptance through the assent form

Exclusion criteria

Exclusion criteria: Children have neurological, neuromuscular diseases or syndromes associated with Cerebral Palsy - CP; children that having been submitted to surgical procedures or neurolytic block in the 12 months prior to the onset of the training sessions; orthopedic deformities with indication for surgery; epilepsy; metal implants in skull or hearing aids; intellectual disorder that would limit the execution of the intellectual activities proposed in the study

Design outcomes

Primary

MeasureTime frame
Functional balance assessed by the Pediatric Balance Scale (points) applied one week before and one, four and eight weeks after the end of the intervention. It is expected to find an increase in the total score of the scale, demonstrating an improvement in functional balance, with a greater effect size for group receiving active galvanic vestibular stimulation compared to sham galvanic vestibular stimulation.

Secondary

MeasureTime frame
Vestibular symptoms assessed by the Vanderbilt Pediatric Dizziness Handicap Inventory for patient caregivers questionnaire (points). A decrease in questionnaire points is expected, demonstrating a reduction in vestibular symptoms after interventions.;Mobility and functional balance assessed by the execution time of the timed up and go test (seconds) performed one week before and one, four and eight weeks after the end of the intervention. It is expected to find a decrease in the test execution time after the interventions.;Gross motor function assessed by the score in the Gross Motor Function Measure – 88 performed one week before and one, four and eight weeks after the end of the intervention. It is expected to find an increase in the total score of the scale, demonstrating an improvement gross motor function after the interventions.;Functional performance assessed by the total score of the Pediatric Evaluation of Disability Inventory (self-care, mobility and social function) performed one week before and one, four and eight weeks after the end of the intervention. It is expected to find an increase in the inventory score demonstrating the improvement in functional performance.;Participation assessed by the Participation and Environment Measure for Children and Youth (points) performed one week before and one, four and eight weeks after the end of the intervention. It is expected to find an increase in participation, demonstrated by the increase in the score after the interventions. ;Adverse effects assessed using a standardized questionnaire that quantifies the perception and intensity of symptoms. Assessments performed before and after each of the ten intervention sessions. It is expected not to find moderate or severe adverse effects during the intervention period.

Countries

Brazil

Contacts

Public ContactAmanda Queiróga

Faculdade de Ciências Médicas da Santa Casa de São Paulo

amanda.queiroga@yahoo.com.br+55-15-997618600

Outcome results

None listed

Source: REBEC (via WHO ICTRP)